Moneycontrol PRO

Ipca Laboratories

Jump to
  • Buy Ipca Laboratories; target of Rs 1710: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1710 in its research report dated February 17, 2026.

  • Buy Ipca Laboratories; target of Rs 1720: Motilal Oswal

    Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 1720 in its research report dated February 16, 2026.

  • Stocks to Watch Today: SBI, Aurobindo Pharma, Ipca Labs, Tata Steel, PFC, REC, Force Motors, Kalyan Jewellers, JK Tyre, Ram Ratna Wires, Atul Auto in focus on 09 February

    Stocks to Watch, 09 Feb: Stocks like State Bank of India, Tata Steel, Shree Cement, Bosch, Oswal Pumps, HBL Engineering, SMS Pharmaceuticals, Sarda Energy and Minerals, Atul Auto, Krishna Institute of Medical Sciences, Ram Ratna Wires, JK Tyre and Industries, Whirlpool of India, and Godawari Power will be in focus on February 9.

  • Trade Spotlight: How should you trade NTPC, Mishra Dhatu Nigam, NMDC, BSE, Larsen & Toubro, Axis Bank, and others on January 30?

    The market may see range-bound trading ahead of the Union Budget scheduled on February 1. Below are some short-term trading ideas to consider.

  • Trade Spotlight: How should you trade Ipca Laboratories, SAIL, Gland Pharma, Indian Bank, Bharat Electronics, and others on January 23?

    The market is expected to consolidate with range-bound trading as long as it trades below the current week’s high. Below are some short-term trading ideas to consider.

  • Trade Spotlight: How should you trade Ipca Labs, MTAR Technologies, Equitas Small Finance Bank, Lupin, IDFC First Bank, and others on January 12?

    The consolidation is likely to continue following a 2.5 percent loss last week. Below are some short-term trading ideas to consider.

  • Chartist Talk: Nifty 50, Nifty Auto signal more downside; bet on these 2 stocks next week, says Sudeep Shah

    Broader markets are also showing signs of strain. This widespread deterioration highlights a clear contraction in risk appetite, reinforcing the need for a cautious, defensive, and highly selective approach in the near term, Sudeep Shah said.

  • Trade Spotlight: How should you trade Siemens, Torrent Pharma, Info Edge, Mphasis, Max Financial Services, and others on December 5?

    The market is expected to remain rangebound until it trades below record high levels. Below are some short-term trading ideas to consider.

  • Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y

  • Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y

  • Buy Ipca Laboratories; target of Rs 1600: Motilal Oswal

    Motilal Oswal is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1600 in its research report dated November 13, 2025.

  • Buy Ipca Laboratories; target of Rs 1600: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1600 in its research report dated November 17, 2025.

  • Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y

  • Accumulate Ipca Laboratories; target of Rs 1525: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 1525 in its research report dated August 13, 2025.

  • Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y

  • Ipca Labs Consolidated March 2025 Net Sales at Rs 2,246.69 crore, up 10.51% Y-o-Y

  • Accumulate Ipca Laboratories; target of Rs 1525: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 1525 in its research report dated May 31, 2025.

  • Stocks to Watch Today: Bajaj Auto, Ipca Labs, Mazagon Dock, Lemon Tree Hotels, Suzlon Energy, NBCC, Ola Electric, Sobha in focus on 30 May

    Stocks to watch, 30 May: Stocks like Procter and Gamble Health, Amara Raja Energy & Mobility, Gujarat Pipavav Port, ICRA, SJVN, NLC India, Harsha Engineers International, IFB Agro Industries, InterGlobe Aviation, Bajaj Auto, Ipca Laboratories,Mazagon Dock Shipbuilders,Lemon Tree Hotels, and Suzlon Energy will be in focus on May 30.

  • Ipca Labs' promoters KIPL may get exemption from making open offer: SEBI's informal guidance

    Kaygee Investments (KIPL) had sort clarification over a merger with another promoter entity PCPL

  • Ipca Labs Consolidated December 2024 Net Sales at Rs 2,245.37 crore, up 9.38% Y-o-Y

  • Trade Spotlight: How should you trade HDFC Bank, Coal India, Granules, BSE, Ipca Labs, UltraTech Cement, and others on March 3?

    The rebound after a severe fall can't be ruled out, but the sustainability is key to watch. Below are some trading ideas for the near term.

  • Accumulate Ipca Laboratories; target of Rs 1700: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 1700 in its research report dated February 14, 2025.

  • Buy IPCA Laboratories; target of Rs 1980: Motilal Oswal

    Motilal Oswal is bullish on IPCA Laboratories recommended buy rating on the stock with a target price of Rs 1980 in its research report dated December 27, 2024.

  • Trade Spotlight: How should you trade Jubilant Foodworks, Ipca Labs, Paytm, Welspun Corp, Campus Activewear, and others on December 30?

    The market is expected to remain rangebound with a positive bias in the upcoming sessions. Below are some trading ideas for the near term.

  • Chartist Talks: Sudeep Shah of SBI Securities explains why he advises buying these 3 stocks for 2025, but bearish on FMCG index

    The chart structure of Nifty 50 is indicating sideways to bearish momentum for the next couple of weeks.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347